Dr Julian Clark is currently Head of Business Development at the Walter and Eliza Hall Institute in Melbourne, responsible for IP management, technology transfer, commercial collaborations,and opportunity development. Julian has more than 30 years of international and cross-cultural business experience in growing and leading technology, research and healthcare enterprises, large and small. Julian also operates his own consulting business, Julian Clark Consulting Pty Ltd., and has had senior executive positions in Sweden, Great Britain, Japan, North America, India and Australia, including being CEO of Pharmacia LKB Biotech AB (Uppsala, Sweden), Chairman/Managing Director of Biochrom Limited (Cambridge, UK), and Chief Operating Officer of Faulding Pharma Limited (Adelaide, Australia).
Julian is a Fellow of the Australian Academy of Technological Sciences and Engineering, and a Member of the Australian Institute of Company Directors. Recently, he was the founding CEO of the Cancer Therapeutics CRC, a Director of Alchemia Limited and Genera Biosystems Limited. He has a PhD from the University of Glasgow and an Honorary Doctorate from the University of South Australia. Currently, Julian is also a Director of Cancer Trials Australia, BioGrid Australia, and BACE Therapeutics.
Fellow of the Australian Academy of Technological Sciences and Engineering